45 results
8-K
EX-99.1
fjco5d675292ks3
24 Apr 23
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:05am
424B5
5fx j3h5xgz8da8fp
13 May 22
Prospectus supplement for primary offering
4:18pm
PRE 14A
a3s3b7s7b4 bh05d
12 Apr 22
Preliminary proxy
4:02pm
424B5
uw9f qd7rwe4
29 Sep 21
Prospectus supplement for primary offering
5:24pm
8-K/A
EX-99.2
7x4c61b8w
7 Jul 21
Financial Statements and Exhibits
8:00am
8-K
EX-99.2
pxw2tshy6pjhbcgi
6 Jul 21
UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease
7:11am